Muscular Dystrophy Muscle Preservation: A Comparative Systematic Review of Exercise and Cannabidiol (CBD) Interventions.
Muscular Dystrophy Muscle Preservation: A Comparative Systematic Review of Exercise and Cannabidiol (CBD) Interventions.
Systematic review finds exercise therapy provides modest but consistent benefits for muscular dystrophy patients while cannabidiol evidence remains limited to preclinical studies.
This systematic review confirms that exercise therapy has an established evidence base for muscular dystrophy management, showing reproducible functional benefits across multiple study designs. The comparison highlights the stark evidence gap between exercise interventions, which have human clinical data, and cannabidiol supplementation, which remains primarily supported by laboratory studies.
For clinicians managing muscular dystrophy patients, this review reinforces exercise as an evidence-based cornerstone of care while cautioning against premature clinical application of CBD. The systematic approach provides a structured framework for counseling patients about realistic expectations from non-pharmacologic interventions in progressive neuromuscular disease.
| Study Type | Systematic Review |
| Population | Patients with muscular dystrophy (various inherited neuromuscular disorders) |
| Intervention | Exercise therapy (aerobic, resistance, functional training) and cannabidiol supplementation |
| Comparator | Comparative analysis between exercise and CBD interventions |
| Primary Outcome | Muscle mass preservation and functional outcomes |
| Key Finding | Exercise shows modest but consistent benefits in functional performance, endurance, and quality of life; CBD evidence limited to preclinical data |
| Journal | Journal of biotechnology and biomedicine |
| Year | Not specified in abstract |
Exercise therapy should remain the primary non-pharmacologic intervention for muscular dystrophy patients based on consistent human evidence showing functional benefits. CBD supplementation lacks sufficient clinical evidence for routine recommendation in this population, despite promising preclinical research.
The abstract does not provide quantitative effect sizes for exercise benefits, specific CBD dosing protocols studied, or direct head-to-head comparisons between interventions. The review cannot establish whether CBD has clinically meaningful effects in humans with muscular dystrophy since the evidence base appears largely preclinical.
Systematic reviews are limited by the quality of underlying studies, and the abstract suggests the CBD evidence base is predominantly preclinical, making clinical extrapolation problematic. The heterogeneous nature of muscular dystrophy conditions may limit the generalizability of pooled exercise findings across different dystrophy subtypes.
Exercise therapy has earned its place as standard care for muscular dystrophy through consistent demonstration of functional benefits in human studies. CBD supplementation, while scientifically interesting, requires clinical validation before integration into evidence-based treatment protocols for these complex neuromuscular disorders.
Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Should I recommend exercise therapy for my patients with muscular dystrophy?
Yes, exercise interventions including aerobic, resistance, and functional training demonstrate modest but consistent benefits in functional performance, endurance, and quality of life. The evidence shows these interventions have acceptable safety profiles when appropriately individualized to the patient’s condition and capabilities.
Is CBD effective for preserving muscle mass in muscular dystrophy patients?
Currently, there is insufficient clinical evidence to recommend CBD for muscle preservation in muscular dystrophy. The available evidence supporting cannabidiol supplementation is limited primarily to preclinical studies, making clinical recommendations premature.
What types of exercise are most beneficial for muscular dystrophy patients?
Aerobic, resistance, and functional training all show benefits for muscular dystrophy patients. The key is individualizing the exercise program to each patient’s specific condition, functional capacity, and disease progression stage to ensure safety and maximize therapeutic benefit.
Are there any safety concerns with exercise therapy in muscular dystrophy?
Exercise therapy demonstrates acceptable safety profiles when appropriately individualized. However, careful assessment and monitoring are essential to prevent overexertion and potential muscle damage, particularly given the progressive nature of these neuromuscular disorders.
What non-pharmacologic options should I prioritize for muscular dystrophy management?
Exercise therapy should be prioritized as an established cornerstone of conservative management with proven benefits. While CBD has emerged as a novel experimental intervention, its use should await more robust clinical evidence given the current limitation to preclinical studies.
